[#DIV28SUPER] Opportunity for behavioral pharmacologist interested in animal welfare

See here https://etendering.ted.europa.eu/cft/cft-display.html?cftId=14842 for a potential opportunity for someone interested in animal welfare. The information specifically mentions a potential interest in behavioral pharmacology. 

It's a 3-year project with a budget of EUR 500k. The deadline for submission of the offer is 27 September.

The main tenderer has to be in the EU ("access to EU market"), but it is possible to subcontract the activities to non-EU organisations/individuals.

 

Details about the procurement procedures in EFSA can be found here

https://www.efsa.europa.eu/en/calls/procurement

https://www.efsa.europa.eu/sites/default/files/assets/EFSAguidancefortenderers.pdf

 

Please do not contact me as I am just passing this along for a colleague.  

--------------------------------------------------------------------------
Chris Newland, Ph. D.

Professor, Department of Psychology                          

226 Thach Hall 

342 West Thach Ave      
Auburn University

Alabama 36849-5212
Office: 334 844-6479       Fax:     334 844-4447
https://cla.auburn.edu/psychology/people/professorial-faculty/chris-newland/

---------------------------------------------------------------------------

 

 

[#DIV28SUPER] Full Division 28 Convention Program

Hello All,

The full APA Division 28 program for the 2023 convention is attached. I want to give a huge thanks to Andrea Vasquez Ferreiro and the Social Media Committee for their help with putting this together! The program includes the Division 28 schedule, as well as a map with conference locations highlighted, information on the NIDA/NIAAA Early Career Investigator Poster Session & Social Hour and the Student Social hour, information on presentations from our award winners, and highlighted talks from outside our division that you won't want to miss!

Please feel free to reach out to me with any questions!
jweafer@uky.edu

Regards,
Jessica

------------------------------------------------------------------
Jessica Weafer, Ph.D.
Associate Professor
Department of Psychology
University of Kentucky
Phone: 859-257-5451
Email: jweafer@uky.edu


_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Membership to Division 28

Hi everyone,

The division of Psychopharmacology and Substance Abuse (Division 28) (soon to be renamed the Society for Psychopharmacology and Substance Use) of the American Psychological Association (APA) was formed in 1967 to allow for psychologists and pharmacologists who were interested in behavioral pharmacology to come together and share their research and ideas. This original concept is still the driving focus behind the division nearly 60 years later.

While the cost to being a member of Division 28 is a bargain ($20 for members and $9 for student members), the value that can be obtained for you is immeasurable. As a member of Division 28, you have access to numerous benefits including access to several listservs, newsletters (sent out three times per year), and opportunities for awards. By being a member of Division 28 in APA, you also have the power APA offers as an advocacy group for various psychological issues that other organizations do not offer. Please note that you do not need to be a member of APA to join Division 28 or to support and maintain your Division 28 membership.

Please consider joining/continuing to support Division 28 and maintain your division benefits. You can join or renew your membership now at https://www.apa.org/renew or here (note, you may first need to log in to your MyAPA account). If you have any difficulties joining/renewing or believe you have received this email in error, please reach out to me at yatesj1@nku.edu.

Also, the following link (https://www.apa.org/science/about/elevating-psychological-science) explains how the APA has been working to improve, promote, and apply psychological science.

Best,

Justin

[#DIV28SUPER] Post-Doc Opportunity at MUSC

Begin forwarded message:

From: "McClure, Erin" <mccluree@musc.edu>

Subject: FW: Div 28 list serve

Date: July 6, 2023 at 10:43:47 AM EDT

To: Ryan Vandrey <rvandrey@jhmi.edu>, "Berry,Meredith S" <mberry@ufl.edu>

      External Email - Use Caution      

 

Study THC/CBD use across the life span!!! 

Drs. Carmela Reichel and Onder Albayram at the Medical University of South Carolina (MUSC) invite applications for a post-doctoral position with competitive salary and benefits. You will be part of the Specialized Center of Research Excellence on Sex and Gender Differences in Addiction. This NIH/NIDA funded project is focused on understanding volitional THC/CBD administration in rats, subsequent relapse to drug seeking, and changes in cognitive processes that result from THC/CBD across the lifespan. This project will also establish sex and age differences in lipidomic and genetic profiles, cell type distribution of CB1 receptors, and changes in endocannabinoid signaling and synaptic plasticity in the hippocampus. Expertise in behavioral testing and rodent surgery is desirable, but not necessary. Fellows will have opportunities to apply for our competitive NIDA T32 training mechanisms as well as an individual fellowships. MUSC boasts an active post-doctoral community with training opportunity in grant writing and career progression. This position is currently open.

 

MUSC is located in the beautiful coastal city of Charleston, a historic seaport famous for its architecture, gardens, and restaurants.  The presence of nearby colleges, beaches and rivers, and a pleasant subtropical climate add to Charleston's many charms.

 

To apply, send a letter of interest, CV, and names of 3 references by e-mail to:

 

Dr. Carmela M Reichel                            E-mail: reichel@musc.edu

Department of Neurosciences 

173 Ashley Avenue, BSB416B

Medical University of South Carolina

Charleston, SC 29425

 

[#DIV28SUPER] Fwd: 2023 CMCR Virtual Symposium, on October 12-13, 2023

FYI

Begin forwarded message:

From: CMCR Symposium <CMCRsymposium@health.ucsd.edu>

Subject: 2023 CMCR Virtual Symposium, on October 12-13, 2023

Date: July 5, 2023 at 3:19:58 PM EDT

To: Undisclosed recipients:;

      External Email - Use Caution      

Save the Date for the 2023 CMCR Symposium!

 

The Center for Medicinal Cannabis Research (CMCR) will host a free, virtual two-day symposium on Thursday and Friday, October 12 and 13, 2023 from 8AM-12Noon Pacific Time (11AM-3PM Eastern Time), Exploring the Entourage: The Therapeutic Potential of Minor Cannabinoids, Terpenes, and Flavonoids. 

 

The symposium will highlight the state of science in medicinal cannabis research. Whereas the majority of current research focuses on delta-9-THC and cannabidiol, the 2023 CMCR Symposium will highlight emerging clinical and translational research on the "other" constituents of cannabis (minor cannabinoids, terpenes, and flavonoids) and the entourage effect.

 

The event is free and open to the public. To register for the event, click here and to get up-to-date information, please visit our website. 

 

Attention trainees and faculty: A virtual poster session highlighting emerging findings in medicinal cannabis research will take place on Thursday, October 12, 2023 from 12Noon-1PM Pacific (3PM-4PM Eastern). If you wish to be considered for a poster presentation, please mark the appropriate box when you register for the event. We will then follow up with you with additional details on how to submit your abstract and prepare your presentation. 

 

We look forward to seeing you at the 2023 CMCR Symposium!

[DIV28ANNOUNCE] Division 28 July Newsletter

Hi all,

 

Please see attached for the latest edition of the newsletter.

 

A few highlights:

• APA 2023 Conference updates from the program chair, Dr. Jessica Weafer
• Division 28 Research spotlight featuring Dr. Orrin Ware
• "Meet the Division 28 Student Representatives!" – a Q&A with our three Division Student Reps.
• An outgoing editorial "Progress and Promise: A Brief Reflection on My Time as Editor of Experimental and Clinical Psychopharmacology" by Dr. Williams Stoops.

 

As always, if you have any comments or questions about the newsletter, or if there is anything you would like to see in future editions, please contact me directly at ksmit398@jh.edu

 

 

Look forward to seeing some of you in DC!

 

~Kirsten

 

[#DIV28SUPER] Virtual OPEN HOUSE: SHARC T32 POSTDOCTORAL FELLOWSHIP OPPORTUNITY

Dear Colleagues,

 

Sharing information about an opening for a T32 postdoctoral fellow with the Southern HIV & Alcohol Research Consortium (SHARC) at the University of Florida and related upcoming virtual open house on July 12^th at 5pm Eastern to learn more about this opportunity. Great faculty and training opportunities there. Reach out to cafrank@ufl.edu with any questions or to register for the open house.

 

Best

 

Rob Leeman

 

 

 

 

 

Christine A. Frank | Academic Assistant 

Southern HIV and Alcohol Research Consortium (SHARC)

SHARC Center for Translational HIV Research

UF| College of Public Health & Health Professions 

UF| College of Medicine 

Emerging Pathogens Institute l 2055 Mowry Road | Gainesville, FL 32610

Email: cafrank@ufl.edu 

http://sharc-research.org/

 

[#DIV28SUPER] Fwd: Reminder - div 55/28 didactic - 6/30/23

All,

See below for info related to the next Div 28/55 research didactic seminar.  I will send around the Zoom link as soon as I get it.

-Ryan

________________

Ryan Vandrey, Ph.D.

Past-President

APA Division 28

http://www.apadivisions.org/division-28/index.aspx

Begin forwarded message:

From: "Nicole M. Bereolos, PhD, MPH, MSCP, CDCES, FADCES" <nbereolos@gmail.com>

Subject: Reminder - div 55/28 didactic - 6/30/23

Date: June 26, 2023 at 9:31:19 PM EDT

To: DIV55DISCUSS@lists.apa.org

      External Email - Use Caution      

Please join us along with division 28 in hosting a webinar by our own Dr Rick Barnett, PsyD

Title:  Emerging Clinical Applications of Psychedelic Medicines

When: Friday, June 30, 2023, 8a PT/10a CT/11a ET

Please RSVP to division.55.apa@gmail.com and the Zoom link will be sent later this week. 

--

Nicole M. Bereolos, PhD, MPH, MSCP, CDCES, FADCES

clinical psychologist/certified diabetes care and education specialist 

McKinney & Sherman, TX

972-768-7994 (p), 972-692-0976 (fax)

ADCES Board of Directors - 2018-2021 

ADCES23 - Behavioral Health track chair

American Psychological Assoc - Div 55 - Society for Prescribing Psychology - Membership Chair - 2021-2023

---

Confidentiality Notice: E-mail is not a secure form of communication as confidentiality cannot be guaranteed. This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. By responding to this email, you agree to its terms.

[#DIV28SUPER] Division 28 Program APA Convention

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] USPSTF Releases Final Recommendation Statements: Screening for Anxiety, Depression, Suicide Risk in Adults

Dear Division 28 Members,

 

The U.S. Preventive Services Task Force (USPSTF) just released two sets of final recommendations and evidence summaries. Clinician summaries are also available on the Task Force website, which provides guidance to primary care clinicians for using the recommendations in practice.

 

• Screening for Anxiety Disorders in Adults

 

• Screening for Depression and Suicide Risk in Adults

 

For any questions, please contact Dr. Raquel Halfond, Senior Director, Evidence-Based Practice and Health Equity, at rhalfond@apa.org.

 

Please disseminate widely to colleagues.

 

Thank you,

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872 | jmarzalik@apa.org

 

APA Land and Labor Acknowledgement
The APA central office in Washington, DC sits on the occupied territory of the Nacotchtank and Piscataway peoples who were forcibly displaced in the 1600s. We pay respects to their elders past and present.

We also acknowledge the unpaid and forced servitude of enslaved Africans and their descendants whose unremittent labor and exploitation were pivotal to the economic growth of our nation and many of whom face ongoing oppression, racism, and violence. We recognize the broken promises and harm done to the first peoples of these lands, the horrors of American slavery, and the painful legacies of inequity affecting many groups that continue to persist.

 

[#DIV28SUPER] Call for Division 28 archival materials

Hi all,

I'm sending the email below on behalf of Ty Schepis, our division Archivist.

Thank you,

Matt

-----------------------------------------------------------------

Dear Members of APA Division 28,

 

The division is working to create an accessible archive of division records and other materials, with the ultimate goal of making this accessible to the entire membership of the division. As a first step, however, we need to collect all materials that are relevant to the division, including board minutes, committee minutes or reports, and any other information that would be worth including in an archive. As the division's Archivist, you can send those materials directly to me (schepis@txstate.edu). Alternatively, if the materials are housed in a cloud storage system like Box, Google Drive, or something similar, you can grant me access to the folder(s), and I can pull the materials that way. Please note that my institution has email file size restrictions, so if you send any big files they may bounce back. In that event, we can use a file transfer service as needed.

 

Please let me know if you have any questions, and thanks for your help with this divisional initiative!

Best wishes,

Ty Schepis

[#DIV28SUPER] AHRQ releases draft systematic review for public comment on ADHD diagnosis and treatment in children and adolescents

Dear Colleagues,

 

The Agency for Healthcare Research and Quality’s Effective Health Care Program recently posted an opportunity to comment on its draft systematic review ADHD Diagnosis and Treatment in Children and Adolescents. The draft systematic review is available for review and public comment until July 24, 2023.

 

The purpose of the review is to assess the evidence on the diagnosis, treatment, and monitoring of ADHD in children and adolescents to inform a planned update of the American Academy of Pediatrics guidelines.

 

Please submit any comments you may have directly to the website at https://effectivehealthcare.ahrq.gov/products/attention-deficit-hyperactivity-disorder/draft-report.

 

You are also invited to share your submitted comments with us to help inform comments submitted from our office. If you wish to share your submitted feedback, please send your comments to Jacob Marzalik at jmarzalik@apa.org by the end of the day July 21, 2023.

 

Please share widely with your networks.

 

Thank you,

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872 | jmarzalik@apa.org

 

APA Land and Labor Acknowledgement
The APA central office in Washington, DC sits on the occupied territory of the Nacotchtank and Piscataway peoples who were forcibly displaced in the 1600s. We pay respects to their elders past and present.

We also acknowledge the unpaid and forced servitude of enslaved Africans and their descendants whose unremittent labor and exploitation were pivotal to the economic growth of our nation and many of whom face ongoing oppression, racism, and violence. We recognize the broken promises and harm done to the first peoples of these lands, the horrors of American slavery, and the painful legacies of inequity affecting many groups that continue to persist.

 

[#DIV28SUPER] Fwd: [DIVTRIO] Influencer Events at the upcoming APA Convention

FYI

Begin forwarded message:

From: FRANK FARLEY <frank.farley@COMCAST.NET>

Subject: [DIVTRIO] Influencer Events at the upcoming APA Convention

Date: June 4, 2023 at 5:17:57 PM EDT

To: DIVTRIO@LISTS.APA.ORG

Reply-To: APA Division Presidential trios communicating about divisional topics <DIVTRIO@LISTS.APA.ORG>

      External Email - Use Caution      

Dear Division Leaders,

The Convention approaches, 8 weeks to go (it's August 3-5). You and your members might find the following 4 sessions of special interest focusing on  major influential contributors to our great discipline.. Each session is a conversation of 50 minutes between the invitee and myself. The first three sessions are all in the same room one after the other (Convention Center Level 1, Room 146c) on Thursday August 3 beginning at 1:00 PM and ending at 3:50PM, just in time to head for the Social Hours and continue  the conversations among your convention colleagues! (NB:The 4th session is on Saturday). These sessions are contributions of Division 26 (Ellis, Pinker) and Division 46 (Chomsky, Evans). The sessions are as follows:

 

 

1) 1:00 PM, Thursday:Rm 146c, Remembering Albert Ellis--Legacy and Life.       Debbie Joffe Ellis     

                                        

2) 2:00 PM, Thursday, Rm 146c, Steven Pinker, Harvard University

 

3) 3:00 PM, Thursday, Rm 146c, Noam Chomsky, University of Arizona & MIT

 

4) 1:00 PM,  Saturday, Rm 147b, Arthur Evans, CEO & Executive VP, APA

 

Join me, it'll be fun, stimulating AND informative!

 

Frank

Former President, APA and Divisions 26,1,3,10,15,32,46,48,52

 

 

 

Click on this link to unsubscribe from the DIVTRIO list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list.

[#DIV28SUPER] FW: Approval of draft NIDA Neuroscience Update

Please see the following funding opportunity announcements from the National Institute on Drug Abuse:

 

Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) RFA-DA-23-012

This Funding Opportunity Announcement (FOA) supports research on the effects of HIV and addictive substances, acting independently or synergistically on blood brain barrier (BBB) structure and function and the involvement of these effects in HIV associated neuropathology.

 

Application Due Date: August 10, 2023

 

------------

Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)  RFA-DA-24-001.

 

This Notice of Funding Opportunity (NOFO) invites grant applications aimed at elucidating pathophysiological mechanisms of HIV-associated neurological disorders (HAND) using ex vivo culturing platforms in the presence of addictive substances, with emphasis on genetic, epigenetic and neuroimmune mechanisms at the single cell to neural circuit levels.

 

Application Due Date: August 10, 2023

 

----------------

Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)  RFA-DA-24-028  
This notice of funding opportunity (NOFO) will support research to improve our understanding of psychedelic drug mechanisms in the context of substance use disorders (SUDs). This NOFO will also support the design and synthesis of chemical biology tools and probes to aid basic research on psychedelics and their translational pharmacology.

Note: This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation.

 

Application Due Date: November 02, 2023

 

 

Other NIDA Funding Opportunities: https://nida.nih.gov/funding/nida-funding-opportunities

 

------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

[#DIV28SUPER] postdoc at VTC

Dear Colleagues-

Please find attached an ad for a postdoc at VTC.

-Bill. 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Fwd: National Institute on Drug Abuse (NIDA) Job Opening

Begin forwarded message:

From: "Aklin, Will (NIH/NIDA) [E]" <aklinwm@nida.nih.gov>

Subject: National Institute on Drug Abuse (NIDA) Job Opening

Date: May 2, 2023 at 4:21:10 PM EDT

To: 'Ryan Vandrey' <rvandrey@jhmi.edu>

      External Email - Use Caution      

Hi Ryan,

 

I hope you are well. Please note and share this Federal job opening with interested Division 28 colleagues.

 

NIDA Division of Therapeutics and Medical Consequences (DTMC) is hiring a Health Scientist Administrator (Substance Use Disorders)

 

The National Institute on Drug Abuse (NIDA), Division of Therapeutics and Medical Consequences (DTMC) is hiring a Health Scientist Administrator focused on clinical research. DTMC administers studies to identify and evaluate the efficacy and/or safety of medications, devices, digital, behavioral, or other therapeutic interventions for substance use disorders (SUDs) and to study the medical consequences of SUDs.

 

In this role, the candidate will provide strategic guidance on potential therapies and technical matters pertaining to the development of treatments for SUDs and program activities for a large research portfolio of grants, cooperative agreements, and contracts. The ideal candidate will have an advanced degree in psychology, psychiatry, pharmacology, or biomedical related field.      

 

Interested candidates are encouraged to apply to the Global Health Scientist Administrator vacancy announcement on USA Jobs (https://www.usajobs.gov/) on May 15^th, 2023. For more information, please contact Will M. Aklin, Ph.D., Chief, Clinical Research Grants Branch, Division of Therapeutics and Medical Consequences, NIDA aklinwm@mail.nih.gov, or 301-827-5909.

 

Best regards,

Will

 

--

Will M. Aklin, Ph.D.

Chief, Clinical Research Grants Branch

Director, Behavioral Therapy Development Program (BTDP)

Division of Therapeutics and Medical Consequences (DTMC)

National Institute on Drug Abuse 

National Institutes of Health

3WFN, Room 08A18, MSC 6016 

301 North Stonestreet Avenue 

Bethesda, MD 20892

301-827-5909

aklinwm@mail.nih.gov

[#DIV28SUPER] Innovation for Substance Use Disorder (I4SUD)- apply now!

Greetings colleagues, 

Please see below an opportunity to participate in a free entrepreneurial training program for persons in the SUD field. Just having an idea or interest in learning more about commercialization in the SUD space is all you need.

---

 

View this email in your browser

Our application is open!   Innovations for Substance Use Disorders is a newly launched Executive Education certificate program for participants to work individually or in teams to assess if their ideas and inventions can be transformed into innovations to address problems in SUDs.   The virtual program features asynchronous and synchronous online activities; a multi-day visit to Carey's Baltimore - Inner Harbor location for workshops, clinical site visits, and community building. Live sessions and virtual mentoring will occur from August 28 - October 16, 2023. The in-person visit with expert panels, community building, SUD clinic visits, and a pitch competition will take place October 17 - October 20, 2023. All participants will have their airfare, meals, and accommodations covered by the sponsoring grant.   The program is open to U.S.-based participants only.

Apply Here